Clinical Trials · NCT01843127
A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Gilead Sciences
- Enrollment
- 24
- Start date
- Apr 2013
- Locations
- 3 sites, United States
- Primary endpoint
- Area under the concentration-time curve (AUC) of plasma glucagon during the standard meal test (SMT)